Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
12
NCT04176328
Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 25, 2019
Completion: Sep 30, 2020